A detailed history of Summit Trail Advisors, LLC transactions in Immunic, Inc. stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 21,600 shares of IMUX stock, worth $25,488. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,600
Previous 18,600 16.13%
Holding current value
$25,488
Previous $24,000 4.17%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.98 - $1.44 $2,940 - $4,320
3,000 Added 16.13%
21,600 $23,000
Q1 2024

Apr 23, 2024

BUY
$1.14 - $1.53 $21,204 - $28,458
18,600 New
18,600 $24,000

Others Institutions Holding IMUX

About IMMUNIC, INC.


  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $36.1M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.